Structures by: Wang H. W.
Total: 29
C27H32N2O4
C27H32N2O4
Journal of medicinal chemistry (2018) 61, 22 9908-9930
a=9.41991(12)Å b=10.11440(12)Å c=23.7285(4)Å
α=90° β=91.6653(13)° γ=90°
C18H11F6NO3
C18H11F6NO3
Chem. Sci. (2015) 6, 3 1923
a=32.403(8)Å b=6.8959(17)Å c=15.250(4)Å
α=90.00° β=97.030(4)° γ=90.00°
C46H28Cu3N2O13,13(C3H7NO)
C46H28Cu3N2O13,13(C3H7NO)
Dalton Trans. (2017)
a=19.387(4)Å b=19.387(4)Å c=60.831(13)Å
α=90° β=90° γ=90°
C50H30Cu3N2O13,12(C3H7NO)
C50H30Cu3N2O13,12(C3H7NO)
Dalton Trans. (2017)
a=19.730(4)Å b=19.730(4)Å c=60.060(10)Å
α=90° β=90° γ=90°
C96H64Cu6N4O26,24(C3H7NO)
C96H64Cu6N4O26,24(C3H7NO)
Dalton Trans. (2017)
a=19.511(2)Å b=19.511(2)Å c=60.340(7)Å
α=90° β=90° γ=90°
C42H28Cu3O15,12C3H7NO
C42H28Cu3O15,12C3H7NO
Dalton Trans. (2017)
a=20.009(1)Å b=20.009Å c=59.029(7)Å
α=90° β=90° γ=90°
C52H36Cu3N2O17,8(C3H7NO)
C52H36Cu3N2O17,8(C3H7NO)
Dalton Trans. (2017)
a=19.627(2)Å b=19.627Å c=60.175(6)Å
α=90° β=90° γ=90°
C92H58Cu6N6O26,24(C3H7NO)
C92H58Cu6N6O26,24(C3H7NO)
Dalton Trans. (2017)
a=19.525(5)Å b=19.525Å c=60.38(2)Å
α=90° β=90° γ=90°
C57H34Mn3N12O26
C57H34Mn3N12O26
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8816-8823
a=15.8891(19)Å b=16.737(2)Å c=22.006(3)Å
α=90° β=90.2715(8)° γ=90°
C57H34Cd3N12O26
C57H34Cd3N12O26
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8816-8823
a=16.033(5)Å b=16.586(5)Å c=22.266(5)Å
α=90.000(5)° β=90.444(5)° γ=90.000(5)°
C79H46N19O28Zn3,4??C5H11NO??
C79H46N19O28Zn3,4??C5H11NO??
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8816-8823
a=12.1150(12)Å b=25.7510(16)Å c=35.5880(13)Å
α=90° β=90.6390(14)° γ=90°
C29H20CdN8O9,C3H7NO,H2O
C29H20CdN8O9,C3H7NO,H2O
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8816-8823
a=8.377(5)Å b=13.546(5)Å c=16.303(5)Å
α=86.182(5)° β=82.757(5)° γ=73.610(5)°
<i>catena</i>-Poly[[chloridobismuth(III)]-μ~3~-1,10-phenanthroline-2,9-dicarboxylato-κ^5^<i>O</i>^2^:<i>N</i>^1^,<i>N</i>^10^,<i>O</i>^9^:<i>O</i>^9^]
C28H12Bi2Cl2N4O8
Acta Crystallographica Section C (2015) 71, 8
a=8.887(6)Å b=9.118(5)Å c=10.099(4)Å
α=111.034(13)° β=115.407(9)° γ=92.872(13)°
1-Methyl-1<i>H</i>-indazole-3-carboxylic acid
C9H8N2O2
Acta Crystallographica Section E (2008) 64, 12 o2257
a=7.5470(15)Å b=14.873(3)Å c=14.924(3)Å
α=90.00° β=93.10(3)° γ=90.00°
2-(4-Chlorophenyl)-5-{3,4-dibutoxy-5-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2- yl]thiophen-2-yl}-1,3,4-oxadiazole
C28H26Cl2N4O4S
Acta Crystallographica Section E (2008) 64, 12 o2298
a=19.215(4)Å b=22.847(5)Å c=14.933(3)Å
α=90.00° β=121.25(3)° γ=90.00°
<i>N</i>-(4-Butanoyl-3-hydroxyphenyl)butanamide
C14H19NO3
Acta Crystallographica Section E (2011) 67, 2 o441
a=6.2870(13)Å b=10.008(2)Å c=21.680(4)Å
α=90.00° β=97.96(3)° γ=90.00°
4-Amino-1-(2-benzoyl-1-phenylethyl)-3-phenyl-1<i>H</i>-1,2,4-triazol- 5(4<i>H</i>)-thione
C23H20N4OS
Acta Crystallographica Section E (2011) 67, 2 o347
a=9.4625(19)Å b=11.340(2)Å c=11.655(2)Å
α=111.80(3)° β=111.01(3)° γ=98.91(3)°
3',6'-Bis(ethylamino)-2',7'-dimethyl-2-{[2-[(<i>E</i>)-3,4- methylenedioxybenzylideneamino]ethyl}spiro[isoindoline-1,9'-xanthen]-3-one
C36H36N4O4
Acta Crystallographica Section E (2009) 65, 8 o1876
a=9.561(4)Å b=12.262(5)Å c=13.005(6)Å
α=93.623(8)° β=92.078(8)° γ=92.827(7)°
(<i>E</i>,<i>E</i>)-3,3'-Dimethyl-1,1'-diphenyl-4,4'-{(ethane-1,2- diyldiimino)bis[(2-furyl)methylidyne]}di-1<i>H</i>-pyrazol-5(4<i>H</i>)-one
C32H28N6O4
Acta Crystallographica Section E (2010) 66, 7 o1534
a=10.7438(6)Å b=7.6999(4)Å c=16.8273(9)Å
α=90.00° β=93.9370(10)° γ=90.00°
Bis[(5-phenyl-1,3,4-thiadiazol-2-yl)sulfanyl]methane
C17H12N4S4
Acta Crystallographica Section E (2010) 66, 12 o3085
a=10.805(2)Å b=19.287(4)Å c=4.0738(8)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4- yl)formamide
C12H13N3O2
Acta Crystallographica Section E (2011) 67, 6 o1310
a=8.4220(17)Å b=9.2950(19)Å c=14.501(3)Å
α=90.00° β=90.00° γ=90.00°
4-(Anthracen-9-yl)-2-phenyl-6-(pyridin-2-yl)pyridine
C30H20N2
Acta Crystallographica Section E (2012) 68, 4 o1210
a=12.6420(3)Å b=14.8499(4)Å c=11.8707(3)Å
α=90.00° β=104.006(2)° γ=90.00°
Bis[bis(2,2-bipyridine-κ^2^<i>N</i>,<i>N</i>')chloridocopper(II)] bis(μ-2,6-pyridinedicarboxylato)- κ^4^<i>O</i>^2^,<i>N</i>,<i>O</i>^6^:<i>O</i>^6^; κ^4^<i>O</i>^2^:<i>O</i>^2^,<i>N</i>,<i>O</i>^6^- bis[aquadichloridobismuthate(III)] pentahydrate
2(C20H16ClCuN4),C14H10Bi2Cl4N2O102,5(H2O)
Acta Crystallographica Section E (2011) 67, 12 m1651
a=22.880(6)Å b=22.044(6)Å c=13.628(4)Å
α=90.00° β=110.130(4)° γ=90.00°
3-(4-Amino-3-methyl-5-sulfanylidene-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)- 3-(2-furyl)-1-phenylpropan-1-one
C16H16N4O2S
Acta Crystallographica Section E (2011) 67, 7 o1609
a=7.3702(8)Å b=24.131(2)Å c=9.2400(10)Å
α=90.00° β=106.745(5)° γ=90.00°
3-(4-Amino-3-phenyl-5-sulfanylidene-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)- 3-(2-chlorophenyl)-1-phenylpropan-1-one
C23H19ClN4OS
Acta Crystallographica Section E (2011) 67, 7 o1794
a=10.559(3)Å b=10.787(4)Å c=10.835(3)Å
α=99.582(2)° β=96.638(4)° γ=115.267(3)°
4-[(<i>Z</i>)-(<i>n</i>-Butylamino)(phenyl)methylidene]-3-methyl- 1-phenyl-1<i>H</i>-pyrazol-5(4<i>H</i>)-one
C21H23N3O
Acta Crystallographica Section E (2012) 68, 4 o969
a=9.5215(9)Å b=14.7867(14)Å c=12.8055(12)Å
α=90.00° β=100.645(2)° γ=90.00°
C22H14F5NO4
C22H14F5NO4
The Journal of organic chemistry (2016) 81, 8 3416-3422
a=9.0667(19)Å b=11.320(2)Å c=19.536(4)Å
α=90.00° β=100.124(3)° γ=90.00°
Sanderite
H4MgO6S
American Mineralogist (2009) 94, 622-625
a=8.8932Å b=8.4881Å c=12.4401Å
α=90° β=90° γ=90°
H10Mg2O13S2
H10Mg2O13S2
American Mineralogist (2009) 94, 1071-1074
a=18.8636Å b=12.3391Å c=8.9957Å
α=90° β=94.568° γ=90°